| Joachim R Brill, MD | |
|
2525 Glenn Hendren Dr, Liberty, MO 64068-9625 | |
| (816) 781-8180 | |
| Not Available |
| Full Name | Joachim R Brill |
|---|---|
| Gender | Male |
| Speciality | Pediatrics - Adolescent Medicine |
| Location | 2525 Glenn Hendren Dr, Liberty, Missouri |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689946766 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2080A0000X | Pediatrics - Adolescent Medicine | 34963 (Missouri) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Joachim R Brill, MD 901 N Forest Ln, Liberty, MO 64068-3362 Ph: () - | Joachim R Brill, MD 2525 Glenn Hendren Dr, Liberty, MO 64068-9625 Ph: (816) 781-8180 |
News Archive
CMC Biologics, a global leader in clinical and commercial manufacturing of therapeutic proteins, and River Vision Development Corporation (River Vision), a private company focused on ophthalmology, announced today that they have entered into an agreement for the process transfer and cGMP production of RV001 (Teprotumumab) – a recombinant monoclonal antibody targeting insulin-like growth factor 1 that is in development for treatment of Grave's Orbitopathy and other indications.
For the third time in one year, the German Institute for Quality and Efficiency in Health Care (IQWiG) dealt with the drug aflibercept. In an early benefit assessment pursuant to the Act on the Reform of the Market for Medicinal Products (AMNOG), the Institute now examined whether aflibercept (trade name: Eylea) offers an added benefit over the appropriate comparator therapy in visual impairment due to macular oedema following occlusion of the central retinal vein.
In a new study by researchers in the UK, the activity of neutralizing antibodies collected from the sera of individuals that contracted COVID-19 during the first wave of the pandemic is tested against variants of concern the B.1.1.7 (or UK) variant and the B.1.351 (or South African) variant, demonstrating somewhat reduced potency of neutralization towards these strains.
Postmenopausal women with diverse gut bacteria exhibit a more favorable ratio of estrogen metabolites, which is associated with reduced risk for breast cancer, compared to women with less microbial variation, according to a new study published in the Endocrine Society's Journal of Clinical Endocrinology & Metabolism (JCEM).
› Verified 4 days ago
Heather Elaine Doss, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 2609 Glenn Hendren Dr, Liberty, MO 64068 Phone: 816-781-7730 | |
Jennifer Lee Neitzel, D.O. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1540 Ne 96th Street, Liberty, MO 64068 Phone: 816-412-2900 Fax: 816-412-2915 | |
Dr. Lori C Baughman, M.D. Pediatrics Medicare: Accepting Medicare Assignments Practice Location: 2609 Glenn Hendren Drive, Liberty, MO 64068 Phone: 816-781-7730 Fax: 816-415-1886 | |
Mikail Kraft, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 1540 Ne 96th St, Liberty, MO 64068 Phone: 816-412-2900 |